Share
Champions of Science

Africa Storytelling Challenge: Meet Elizabeth Kperrun

Share
The CEO of Zenafri Limited, Kperrun has developed educational apps and animated video content for children in Africa. Using modern-day technology, her award-winning products help students understand the importance of preserving and promoting African culture.

lizabeth Kperrun has taken what can be a daunting task for students—learning other languages—and managed to make it fun. Through Zenafri Limited, the company she runs, Kperrun has created educational apps for African kids of all ages. To date, her apps have been downloaded more than 120,000 times, and daily active users average 2,500.

I believe it is important to tell stories of science; such stories inspire the younger generation, just as they inspired us to innovate and create an even better world.

In the video below, the Nigerian tech powerhouse shares what helps fuel her achievements. Her passion for educating children and for preserving her rich, African heritage is nothing short of inspiring.

About the Africa Storytelling Challenge
The inaugural Champions of Science®—Africa Storytelling Challenge took place between May and August 2018. Open to all scientists doing innovative work in Africa, the contest drew more than 100 submissions. An independent selection committee of scientists, policymakers and science journalists reviewed the applications and selected the winners. Each winner will be awarded $5,000 and will have the opportunity to share their stories at the 2019 American Association for the Advancement of Science (AAAS) annual meeting in Washington, D.C.

Champions of Science is a multifaceted initiative to convene and catalyze champions of science, and engage people of all generations and backgrounds to see the unlimited opportunities that science brings.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue